EDGAR·FLOW

ALIGN TECHNOLOGY INC — Form 8-K

Filed November 18, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 24/100
What the filing says
Align Technology appointed Paul J. Clancy (former CFO of Alexion and Biogen) as a director effective immediately (November 18, 2026) and Ian Bell (COO of Alcon) as a director effective December 10, 2026. The board will expand to 13 directors until December 31, 2026, when it will return to 12 following C. Raymond Larkin Jr.'s retirement. Both will be included in the 2027 proxy slate.
Why this rating

Board appointments are routine governance events. While both directors bring strong pharma/medical device experience, board composition changes do not alter business operations or financial trajectory for a $11.1B company.

View original filing on SEC.gov ↗ ALGN · stock on Yahoo Finance ↗

See more from November 18, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.